Full Text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Two-dimensional (2D) nanomaterials (e.g., graphene) have shown to have a high potential in future biomedical applications due to their unique physicochemical properties such as unusual electrical conductivity, high biocompatibility, large surface area, and extraordinary thermal and mechanical properties. Although the potential of graphene as the most common 2D nanomaterials in biomedical applications has been extensively investigated, the practical use of other nanoengineered 2D materials beyond graphene such as transition metal dichalcogenides (TMDs), topological insulators (TIs), phosphorene, antimonene, bismuthene, metal–organic frameworks (MOFs) and MXenes for biomedical applications have not been appreciated so far. This review highlights not only the unique opportunities of 2D nanomaterials beyond graphene in various biomedical research areas such as bioelectronics, imaging, drug delivery, tissue engineering, and regenerative medicine but also addresses the risk factors and challenges ahead from the medical perspective and clinical translation of nanoengineered 2D materials. In conclusion, the perspectives and future roadmap of nanoengineered 2D materials beyond graphene are outlined for biomedical applications.

Details

Title
Two-Dimensional Nanomaterials beyond Graphene for Biomedical Applications
Author
Derakhshi, Maryam 1 ; Daemi, Sahar 2   VIAFID ORCID Logo  ; Shahini, Pegah 1 ; Habibzadeh, Afagh 3 ; Mostafavi, Ebrahim 4   VIAFID ORCID Logo  ; Ali Akbar Ashkarran 1   VIAFID ORCID Logo 

 Precision Health Program and Department of Radiology, Michigan State University, East Lansing, MI 48824, USA; [email protected] (M.D.); [email protected] (P.S.) 
 Department of Chemistry, University of California Davis, One Shields Avenue, Davis, CA 95616, USA; [email protected] 
 Department of Chemistry, University of British Columbia, Vancouver, BC V6T 1Z1, Canada; [email protected] 
 Stanford Cardiovascular Institute, Stanford, CA 94305, USA; [email protected]; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA 
First page
27
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
20794983
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2642415663
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.